Berry & Associates Awarded $749k Phase II SBIR Grant For Oligonucleotide Purification Method

DEXTER, Mich.--(BUSINESS WIRE)--April 5, 2006--Berry & Associates, Inc. announced today that the company has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the National Institute of General Medical Sciences (NIGMS), one of the National Institutes of Health (NIH). The grant, $748,727 over two years, will be used to develop methods for the purification of synthetic pieces of DNA and RNA for applications in genetics, diagnostics, and therapeutics.

MORE ON THIS TOPIC